These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 22658284)

  • 1. High-risk drug-use practices among a large sample of Australian prisoners.
    Kinner SA; Jenkinson R; Gouillou M; Milloy MJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):156-60. PubMed ID: 22658284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resumption of injecting drug use following release from prison in Australia.
    Winter RJ; Young JT; Stoové M; Agius PA; Hellard ME; Kinner SA
    Drug Alcohol Depend; 2016 Nov; 168():104-111. PubMed ID: 27635997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences among regular injecting drug users in Sydney, Australia, 1996-2003.
    Breen C; Roxburgh A; Degenhardt L
    Drug Alcohol Rev; 2005 Jul; 24(4):353-8. PubMed ID: 16234131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate substitution treatment to reduce in-prison drug injection: a natural experiment.
    Kinner SA; Moore E; Spittal MJ; Indig D
    Int J Drug Policy; 2013 Sep; 24(5):460-3. PubMed ID: 23465644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study.
    Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J;
    Int J Drug Policy; 2018 Apr; 54():18-25. PubMed ID: 29367011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-fatal overdose among adult prisoners with a history of injecting drug use in two Australian states.
    Moore E; Winter R; Indig D; Greenberg D; Kinner SA
    Drug Alcohol Depend; 2013 Nov; 133(1):45-51. PubMed ID: 23866987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
    Falster K; Kaldor JM; Maher L;
    J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
    Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
    Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies.
    Werb D; Kerr T; Small W; Li K; Montaner J; Wood E
    J Public Health (Oxf); 2008 Jun; 30(2):126-32. PubMed ID: 18387974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
    Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
    Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study.
    Winter RJ; Stoové M; Agius PA; Hellard ME; Kinner SA
    Drug Alcohol Rev; 2019 Mar; 38(3):254-263. PubMed ID: 30569550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hepatitis C virus infection among street youths.
    Roy E; Haley N; Leclerc P; Boivin JF; Cédras L; Vincelette J
    CMAJ; 2001 Sep; 165(5):557-60. PubMed ID: 11563207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
    PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.